ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 21683 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 21683; 2) Community: the network communities that were significantly associated with the response to NSC 21683; 3) Molecule: the relationships between components within communities and NSC 21683; 4) MDR: the compounds that were significantly associated with the NSC 21683.

NSC Compound Enrichment Correlation
NSC 665496 Null 0.000610795106687085 0.66553619
NSC 696075 Null 0.000610795106687085 0.22119493
NSC 749245 N-(3-{(2E)-3-[4-(diethylamino)phenyl]prop-2-enoyl}phenyl)methanesulfonamide 0.000610795106687085 0.40439293
NSC 626878 Cyclopentanone, 2-[(dimethylamino)methyl]-5-pentylidene-, hydrochloride 0.000613655894404025 0.31671951
NSC 628115 9-N(N'-chloroethyl-N'-methyl-1,2-diaminoethyl) 2 methoxyacridine dihydrochloride 0.000613655894404025 0.3976728
NSC 711102 Null 0.000613655894404025 -0.10660927
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.000706163530262832 0.46010263
NSC 255111 19-Formylgeldanamycin N-piperidinoimine 0.000706163530262832 0.36321506
NSC 328785 ANTINEOPLASTIC-328785 0.000706163530262832 0.2709489
NSC 683332 Spiro[2a,8a-epoxyanthra[2,3-b]oxirene- 2-(1aH),2'-naphtho[1,8-de][1,3]dioxin]-3,8(9H,9aH)-dione, 9-hydroxy-, stereoisomer 0.000706163530262832 0.37231514
Total:99  Current:3    [First] [Prev] [Next] [Last]